Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, CA, USA.
Med Phys. 2017 Oct;44(10):5001-5009. doi: 10.1002/mp.12479. Epub 2017 Aug 30.
Single-isocenter, volumetric-modulated arc therapy (VMAT) stereotactic radiosurgery (SRS) for multiple brain metastases (multimets) can deliver highly conformal dose distributions and reduce overall patient treatment time compared to other techniques. However, treatment planning for multimet cases is highly complex due to variability in numbers and sizes of brain metastases, as well as their relative proximity to organs-at-risk (OARs). The purpose of this study was to automate the VMAT planning of multimet cases through a knowledge-based planning (KBP) approach that adapts single-target SRS dose predictions to multiple target predictions.
Using a previously published artificial neural network (ANN) KBP system trained on single-target, linac-based SRS plans, 3D dose distribution predictions for multimet patients were obtained by treating each brain lesion as a solitary target and subsequently combining individual dose predictions into a single distribution. Spatial dose distributions di(r→) for each of the i = 1…N lesions were merged using the combination function d(r→)=∑iNdin(r→)1/n. The optimal value of n was determined by minimizing root-mean squared (RMS) difference between clinical multimet plans and predicted dose per unit length along the line profile joining each lesion in the clinical cohort. The gradient measure GM=[3/4π]1/3V50%1/3-V100%1/3 is the primary quality metric for SRS plan evaluation at our institution and served as the main comparative metric between clinical plans and the KBP results. A total of 41 previously treated multimet plans, with target numbers ranging from N = 2-10, were used to validate the ANN predictions and subsequent KBP auto-planning routine. Fully deliverable KBP plans were developed by converting predicted dose distribution into patient-specific optimization objectives for the clinical treatment planning system (TPS). Plan parity was maintained through identical arc configuration and target normalization. Overall plan quality improvements were quantified by calculating the difference between SRS quality metrics (QMs): ΔQM = QM - QM . In addition to GM, investigated QMs were: volume of brain receiving ≥ 10 Gy (V ), volume of brain receiving ≥ 5 Gy (ΔV ), heterogeneity index (HI), dose to 0.1 cc of the brainstem (D ), dose to 1% of the optic chiasm (D ), and interlesion dose (D ). In addition to this quantitative analysis, overall plan quality was assessed via blinded plan comparison of the manual and KBP treatment plans by SRS-specializing physicians.
A dose combination factor of n = 8 yielded an integrated dose profile RMS difference of 2.9% across the 41-patient cohort. Multimet dose predictions exhibited ΔGM = 0.07 ± 0.10 cm against the clinical sample, implying either further normal tissue sparing was possible or that dose predictions were slightly overestimating achievable dose gradients. The latter is the more likely explanation, as this bias vanished when dose predictions were converted to deliverable KBP plans ΔGM = 0.00 ± 0.08 cm. Remaining QMs were nearly identical or showed modest improvements in the KBP sample. Equivalent QMs included: ΔV = 0.37 ± 3.78 cc, ΔHI = 0.02 ± 0.08 and ΔD = -2.22 ± 171.4 cGy. The KBP plans showed a greater degree of normal tissue sparing as indicated by brain ΔV = 4.11± 24.05 cc, brainstem ΔD = 42.8 ± 121.4 cGy, and chiasm ΔD = 50.8 ± 83.0 cGy. In blinded review by SRS-specializing physicians, KBP-generated plans were deemed equivalent or superior in 32/41(78.1%) of the cases.
Heuristic KBP-driven automated planning in linac-based, single-isocenter treatments for multiple brain metastases maintained or exceeded overall plan quality.
与其他技术相比,容积调强弧形治疗(VMAT)立体定向放射外科(SRS)单次等中心治疗多个脑转移瘤(multimet)可提供更高的适形剂量分布,并减少整体患者治疗时间。然而,由于脑转移瘤的数量和大小以及它们与危及器官(OAR)的相对接近程度的变化,多靶区病例的治疗计划非常复杂。本研究的目的是通过基于知识的规划(KBP)方法自动规划多靶区病例,该方法将单靶区 SRS 剂量预测适应于多个靶区预测。
使用之前发表的基于直线加速器的单靶区 SRS 计划的人工神经网络(ANN)KBP 系统,通过将每个脑病变视为单独的靶区,并随后将个体剂量预测合并到单个分布中,获得多靶区患者的 3D 剂量分布预测。通过使用组合函数 d(r→)=∑iNdin(r→)1/n 将每个病变 i = 1…N 的空间剂量分布 di(r→) 合并。通过最小化临床多靶区计划和沿临床队列中每个病变的线剖面的单位长度预测剂量之间的均方根(RMS)差异,确定 n 的最佳值。梯度测量 GM=[3/4π]1/3V50%1/3-V100%1/3 是我们机构 SRS 计划评估的主要质量指标,并作为临床计划和 KBP 结果之间的主要比较指标。使用之前治疗的 41 个多靶区计划,靶区数量从 N = 2 到 10,验证 ANN 预测和随后的 KBP 自动规划例程。通过将预测剂量分布转换为临床治疗计划系统(TPS)的患者特定优化目标,开发了可完全交付的 KBP 计划。通过相同的弧形配置和靶区归一化保持了整体计划质量的一致性。通过计算 SRS 质量指标(QM)之间的差异来量化整体计划质量的提高:ΔQM = QM - QM 。除 GM 外,还研究了 QM 包括:脑接受 ≥10Gy 的体积(V )、脑接受 ≥5Gy 的体积(ΔV )、不均匀性指数(HI)、脑干 0.1cc 剂量(D )、视神经交叉 1%剂量(D )和病变间剂量(D )。除了定量分析外,通过 SRS 专家对手动和 KBP 治疗计划的盲法计划比较评估整体计划质量。
在 41 例患者队列中,当剂量组合因子 n = 8 时,得到了集成剂量分布 RMS 差异为 2.9%。多靶区剂量预测表现出 ΔGM = 0.07 ± 0.10 cm 与临床样本相比,这意味着可能有进一步的正常组织保护,或者剂量预测略微高估了可实现的剂量梯度。后一种解释更有可能,因为当将剂量预测转换为可交付的 KBP 计划时,这种偏差消失了 ΔGM = 0.00 ± 0.08 cm。其余的 QM 几乎相同或在 KBP 样本中略有改善。等效 QM 包括:ΔV = 0.37 ± 3.78 cc、ΔHI = 0.02 ± 0.08 和 ΔD = -2.22 ± 171.4 cGy。KBP 计划显示出更大程度的正常组织保护,这表明脑 ΔV = 4.11 ± 24.05 cc、脑干 ΔD = 42.8 ± 121.4 cGy 和视交叉 ΔD = 50.8 ± 83.0 cGy。在 SRS 专家的盲法审查中,KBP 生成的计划在 32/41(78.1%)的病例中被认为是等效或更好的。
基于直线加速器的单次等中心多脑转移瘤治疗的启发式 KBP 驱动自动规划保持或超过了整体计划质量。